Scholars@Duke publication: A Case for Market-Based Costs in Determining Cost-Effectiveness: The Hepatitis C Example. Washington, DC: Avalere Health.

A Case for Market-Based Costs in Determining Cost-Effectiveness: The Hepatitis C Example. Washington, DC: Avalere Health.

Publication , Report

Leinward, B; Hughes, K; Sorenson, C; Johnsrud, M

Duke Scholars

Author Corinna Sorenson Population Health Sciences

Citation

APA

Chicago

ICMJE

MLA

NLM

Leinward, B., Hughes, K., Sorenson, C., & Johnsrud, M. (n.d.). A Case for Market-Based Costs in Determining Cost-Effectiveness: The Hepatitis C Example. Washington, DC: Avalere Health.

Leinward, Brian, Kathy Hughes, Corinna Sorenson, and Michael Johnsrud. “A Case for Market-Based Costs in Determining Cost-Effectiveness: The Hepatitis C Example. Washington, DC: Avalere Health.,” n.d.

Leinward B, Hughes K, Sorenson C, Johnsrud M. A Case for Market-Based Costs in Determining Cost-Effectiveness: The Hepatitis C Example. Washington, DC: Avalere Health.

Leinward, Brian, et al. A Case for Market-Based Costs in Determining Cost-Effectiveness: The Hepatitis C Example. Washington, DC: Avalere Health.

Leinward B, Hughes K, Sorenson C, Johnsrud M. A Case for Market-Based Costs in Determining Cost-Effectiveness: The Hepatitis C Example. Washington, DC: Avalere Health.